Back to ACRS
MARSHALL WACE, LLP ACRS Position History
Aclaris Therapeutics, Inc. • Healthcare
Quarters held
15
Latest value
$3.1M
Q3 2026
Peak value
$5M
First seen
Q2 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2023 | $315K |
| Q4 2024 | $1.5M |
| Q4 2024 | $5M |
| Q1 2025 | $1M |
| Q1 2025 | $2.5M |
| Q2 2025 | $943K |
| Q2 2025 | $2.3M |
| Q3 2025 | $1M |
| Q3 2025 | $2.2M |
| Q4 2025 | $83K |
| Q4 2025 | $1.4M |
| Q1 2026 | $46K |
| Q1 2026 | $2.6M |
| Q3 2026 | $223K |
| Q3 2026 | $3.1M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $3.1M | 588.5K | — | — |
| Q3 2026 | $223K | 42.3K | — | — |
| Q1 2026 | $2.6M | 700.7K | — | — |
| Q1 2026 | $46K | 12.3K | — | — |
| Q4 2025 | $1.4M | 458.1K | — | — |
| Q4 2025 | $83K | 27.4K | — | — |
| Q3 2025 | $2.2M | 1.17M | — | — |
| Q3 2025 | $1M | 544.0K | — | — |
| Q2 2025 | $2.3M | 1.63M | — | — |
| Q2 2025 | $943K | 664.3K | — | — |
| Q1 2025 | $2.5M | 1.66M | — | — |
| Q1 2025 | $1M | 654.2K | — | — |
| Q4 2024 | $5M | 2.02M | — | — |
| Q4 2024 | $1.5M | 617.6K | — | — |
| Q2 2023 | $315K | 30.4K | — | — |